Compare BEAM & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAM | VAC |
|---|---|---|
| Founded | 2017 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.2B |
| IPO Year | 2019 | 2011 |
| Metric | BEAM | VAC |
|---|---|---|
| Price | $25.19 | $95.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $50.75 | ★ $75.13 |
| AVG Volume (30 Days) | ★ 2.6M | 392.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.68% |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | $24,000.00 | ★ $5,032,000,000.00 |
| Revenue This Year | N/A | $54.23 |
| Revenue Next Year | $33.77 | $2.90 |
| P/E Ratio | ★ N/A | $146.59 |
| Revenue Growth | ★ 33.33 | 1.31 |
| 52 Week Low | $15.60 | $44.58 |
| 52 Week High | $38.26 | $105.97 |
| Indicator | BEAM | VAC |
|---|---|---|
| Relative Strength Index (RSI) | 30.23 | 48.30 |
| Support Level | $24.80 | $93.00 |
| Resistance Level | $33.32 | $102.30 |
| Average True Range (ATR) | 1.99 | 3.33 |
| MACD | -0.94 | -1.08 |
| Stochastic Oscillator | 1.83 | 26.95 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.